Detect
PrivateLast Round
Grant
Feb 8, 2022
Total Funding Raised
$31M
Company Overview
Detect operates in Healthcare & Life Sciences and is based in Guilford, Connecticut. Its latest recorded funding round was a Grant round in February 2022.
Detect is a biotechnology company that develops a molecular diagnostic testing platform designed to provide rapid, accurate, and accessible diagnostic results at the point of need.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2C
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Detect Comparables
Compare Detect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptitude Medical | 85% | |
| Visby Medical | 81% | |
| Prominex, Inc. | 81% |
For institutional investors. Book with your work email.
Detect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 8, 2022 | ||||
| VC Round | Dec 15, 2021 | ||||
| Grant | Oct 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Detect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Foresite Capital | VC Round |
| Biomedical Advanced Research and Development Authority | Grant |
| 4Catalyzer | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2021
Received $8.1M from NIH RADx and HHS.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 4, 2026
As of Sep '26, Detect is developing the world’s first rapid diagnostic test for Crimean-Congo haemorrhagic fever, reducing case identification time from days to around 30 minutes.
For institutional investors. Book with your work email.
Detect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Detect's valuation, stock price, and market status.
Is Detect a public or private company?
Detect is a private company.
What is the current stock price of Detect?
Detect is a private company, so its shares have no public market price. Caplight tracks Detect's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Detect worth (valuation)?
Valuation information for Detect is not publicly available.
Can I buy Detect stock?
Detect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Detect's last funding round?
Detect's most recent funding round was Grant on February 8, 2022.
Who are the main investors in Detect?
Key investors in Detect include NIH RADx, Biomedical Advanced Research and Development Authority.
Will Detect IPO soon?
No public IPO plans have been announced for Detect.
How can I track Detect secondary market activity?
Caplight tracks bids, offers, and trades in Detect's shares on secondary markets.